Table 1.
Patient demographics.
| Demographics | Combined | Radiation naïve | Pre-operative radiation |
|---|---|---|---|
| n (%) N = 75 | n (%) N = 35 | n (%) N = 40 | |
| Age (years) | |||
| 40–49 | 11 (14.7%) | 5 (14.3%) | 6 (15.0%) |
| 50–59 | 14 (18.7%) | 3 (8.6%) | 11 (27.5%) |
| 60–69 | 25 (33.3%) | 13 (37.1%) | 12 (30.0%) |
| 70–79 | 17 (22.7%) | 9 (25.7%) | 8 (20.0%) |
| 80–89 | 7 (9.3%) | 5 (14.3%) | 2 (5.0%) |
| 90–99 | 1(1.3%) | 0 (0.0%) | 1 (2.5%) |
| Gender | |||
| Female | 46 (61.3%) | 18 (51.4%) | 28 (70.0%) |
| Male | 29 (38.7%) | 17 (48.6%) | 12 (30.0%) |
| Primary cancer site | |||
| Breast | 22 (29.3%) | 8 (22.9%) | 14 (35.0%) |
| Lung | 12 (16.0%) | 5 (14.3%) | 7 (17.5%) |
| Prostate | 12 (16.0%) | 7 (20.0%) | 5 (12.5%) |
| Renal cell | 10 (13.3%) | 5 (14.3%) | 5 (12.5%) |
| Multiple myeloma | 5 (6.7%) | 2 (5.7%) | 3 (7.5%) |
| Others | 13 (17.3%) | 7 (20.0%) | 6 (15.0%) |
| Unknown | 1 (1.3%) | 1 (2.9%) | 0 (0.0%) |